Mag 2 Pwr 1.5gm/Pck 1.5 g Powder is a Health Canada–registered human drug (DIN 00741701) held by Laboratoires Charton Laboratories, containing Magnesium Pidolate. Health Canada lists its status as Cancelled Post Market (status date 16 Jan 1999). Nexara Health has matched 1 registration of Magnesium Pidolate across 1 other regulated market.
Health Canada registration
| DIN | 00741701 |
|---|---|
| Brand name | Mag 2 Pwr 1.5gm/Pck |
| Active ingredient | Magnesium Pidolate |
| Strength | 1.5 g |
| Dosage form | Powder |
| Route | Oral |
| Company | Laboratoires Charton Laboratories |
| Status | Cancelled Post Market — 16 Jan 1999 |
| Class | Human |
| ATC | |
| AHFS | 88:29.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Magnesium Pidolate registered in other markets
1 registration of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| MA | Maximag | — | 1.5 G | Solution Buvable | G | CNOPS liste des medicaments |
See every manufacturer of Magnesium Pidolate worldwide →
Regulator price references for Magnesium Pidolate
Published list or reimbursement prices for Magnesium Pidolate presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| MA | Maximag | 1500mg | 1 BOITE 30 AMPOULE BUVABLE | 61.20 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Mag 2 Pwr 1.5gm/Pck (DIN 00741701) marketed in Canada?
No. Health Canada lists DIN 00741701 as Cancelled Post Market as of 16 Jan 1999.
Who holds the Canadian licence for this product?
Laboratoires Charton Laboratories is the company of record in the Health Canada Drug Product Database.
Is Magnesium Pidolate registered outside Canada?
Yes — Nexara Health has matched 1 registration in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00741701, status date 1999-01-16; national medicine registries: CNOPS liste des medicaments; price sources: CNOPS liste des medicaments. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00741701, status date 1999-01-16; national medicine registries: CNOPS liste des medicaments; price sources: CNOPS liste des medicaments.
Health Canada Drug Product Database (DPD), DIN 00741701, status date 1999-01-16; national medicine registries: CNOPS liste des medicaments; price sources: CNOPS liste des medicaments. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.